MONTE ROSA THERAPEUTICS INC. - COMMON STOCK

5.5200

24-January-25 16:45:00

15 minutes delayed

Stocks

+0.0200

+0.36%

Today's range

5.1500 - 5.6100

ISIN

N/A

Source

NASDAQ

Monte Rosa Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

22 Nov 2021 07:30:00 By Nasdaq GlobeNewswire
Monte Rosa Therapeutics Announces First Development Candidate and Reports Third Quarter 2021 Financial Results and Business Updates

10 Nov 2021 07:30:01 By Nasdaq GlobeNewswire
Monte Rosa Therapeutics to Present at 4th Annual Targeted Protein Degradation Summit

20 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer

07 Oct 2021 09:00:02 By Nasdaq GlobeNewswire
Monte Rosa Therapeutics to Present Late-breaking Preclinical Data on Targeting GSPT1 for Myc-driven Cancers at AACR-NCI-EORTC Virtual International Conference

30 Sep 2021 16:30:00 By Nasdaq GlobeNewswire
Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® Indexes

10 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

08 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

12 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

23 Jun 2021 20:20:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.